SCHEMBL6767475

SCHEMBL6767475

COc1cc2nc(N3CCCN(C(=O)N4CCOCC4)CC3)cc(N)c2c(-c2ccccc2C(F)(F)F)c1OC

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 3/20 0.42
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 2/20 0.38
HSD17B10 Q99714 2/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
ITGB2 P05107 1/20 0.38
ICAM1 P05362 1/20 0.38
ITGAL P20701 1/20 0.38
CNR2 P34972 2/20 0.38
GBA1 P04062 1/20 0.36
RBP4 P02753 1/20 0.35
LMNA P02545 1/20 0.35
S1PR1 P21453 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6764936 0.94 AKR1C3 (0.39) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6765566 0.87 AKR1C3 (0.45) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6767472 0.87 AKR1C3 (0.43) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6764933 0.86 CNR2 (0.39) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7013535 0.85 KDM4E (0.46) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6771678 0.84 AKR1C3 (0.40) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL4603370 0.84 AKR1C3 (0.41) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7249486 0.84 AKR1C3 (0.40) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL7007486 0.83 AKR1C3 (0.41) AKR1C3KDM4EALDH1A1HPGDHSD17B10
SCHEMBL6772466 0.83 AKR1C3 (0.46) AKR1C3KDM4EALDH1A1HPGDHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6750214-B2 PARTICULARLY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA COLLIS ALAN JOHN (US) 2004-06-15 US disclosed
US-6642242-B2 Antiproliferative agents to treat benign prostatic hyperplasia PFIZER INC. 2003-11-04 US disclosed
US-6103738-A Quinoline and quinazoline compounds useful in therapy PFIZER INC. (US) 2000-08-15 US disclosed
EP-0877734-B1 QUINOLINE AND QUINAZOLINE COMPOUNDS USEFUL IN THERAPY PFIZER RES & DEV (IE) 2000-07-12 EP disclosed